This HTML5 document contains 126 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n10http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q36628049
rdf:type
wikibase:Item
schema:description
scienca artikolo scientific article published on October 2006 επιστημονικό άρθρο naučni članak 2006年论文 2006년 논문 научная статья 2006年論文 2006年論文 article científic vědecký článek artículo científico publicado en 2006 tudományos cikk სამეცნიერო სტატია מאמר מדעי artikulong pang-agham vitskapeleg artikkel 2006年论文 2006年の論文 vedecký článok scientific article published on October 2006 บทความทางวิทยาศาสตร์ 2006年论文 articolo scientifico научна статия 2006年论文 2006年論文 teaduslik artikkel artigo científico article scientifique 2006年论文 مقالة علمية نشرت في أكتوبر 2006 artykuł naukowy artikull shkencor artikel ilmiah vitenskapelig artikkel bilimsel makale 2006年论文 bài báo khoa học 2006 nî lūn-bûn অক্টোবর ২০০৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2006年論文 videnskabelig artikel wissenschaftlicher Artikel scientific article published on October 2006 мақолаи илмӣ artigo científico научни чланак vetenskaplig artikel artigo científico artículu científicu espublizáu en 2006 наукова стаття, опублікована в жовтні 2006 2006年論文 wetenschappelijk artikel article scientific tieteellinen artikkeli научни чланак articol științific
p:P577
wds:Q36628049-0C7A4818-5669-472E-BA75-61EF8A8B93B1
wdt:P577
2006-10-01T00:00:00Z
p:P407
wds:Q36628049-4083A838-F510-4674-9D40-7EBDEF5CDBBA
wdt:P407
wd:Q1860
p:P2093
wds:Q36628049-30940CAE-F650-4F5F-BCFE-64D216566A18 wds:Q36628049-217B69ED-E477-4CCE-8BC8-0E464E531342 wds:Q36628049-050B92F9-455C-4B4C-A271-AA7CF89DD030 wds:Q36628049-DFA9E144-ECA1-4941-A70B-00448B5C9F73 wds:Q36628049-B8B57B97-3D4B-44F9-9152-59F48652E6E2 wds:Q36628049-5B058F40-7ADC-4856-B5FD-A922920CA06B wds:Q36628049-59D35533-7FD5-4B5C-B93D-2D805D21D36F wds:Q36628049-4BEB2995-618D-4936-957B-0242BBACC100 wds:Q36628049-F602E036-45CF-4AD1-990D-967EE8250BFA wds:Q36628049-FC3DFC26-370B-450C-91E8-85CE9BE33CF7 wds:Q36628049-EAE86843-B62C-4739-832C-32E244863130
wdt:P2093
David J Mauro Nozar Azarnia Barry Mirtsching Robert J Mayer Philip Stella Philip Gold Allen L Cohn Shirin Khambata-Ford Eric K Rowinsky Andrew W Pippas Zenta Tsuchihashi
rdfs:label
Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines
skos:prefLabel
Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines
schema:name
Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines
p:P50
wds:Q36628049-2575218B-3DB3-4061-A632-06B947669C03 wds:Q36628049-3FBE0D19-AB7B-4EF6-B339-B6E5B6D00E12
wdt:P50
wd:Q37068027 wd:Q89668545
p:P1476
wds:Q36628049-BD7CD76C-6CE7-4B77-9ED4-F4B7AC6DAFEF
wdt:P1476
Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines
p:P304
wds:Q36628049-8FAE8CF8-631B-4020-A302-7C1832C939C4
wdt:P304
4914-4921
p:P31
wds:Q36628049-E45B65FF-61A5-4DD4-97C6-B0D46AAA0B04
wdt:P31
wd:Q13442814
p:P921
wds:Q36628049-530E1467-C55C-4A76-968B-7FF6044D5DA0 wds:Q36628049-3B744793-C603-4D28-B44E-2CCD8889937E wds:Q36628049-DAA2F1EF-A92D-4FF5-9807-77B8E84D20CA wds:Q36628049-8704311A-2703-428F-9206-13883FD14C44 wds:Q36628049-E17E6443-46EF-4B37-A2DD-98B38E666301
wdt:P921
wd:Q422327 wd:Q108607277 wd:Q6934595 wd:Q420296 wd:Q412197
p:P698
wds:Q36628049-668F7C7E-B9B4-4F9D-9C5C-82E0D71EAB44
wdtn:P698
n11:17050875
wdt:P698
17050875
p:P1433
wds:Q36628049-D5B4C4F3-4C07-4582-A80A-D66F96A8FC18
wdt:P1433
wd:Q400292
p:P433
wds:Q36628049-E97BC3B2-C7A9-4679-ACA0-7B1B275A0E91
p:P478
wds:Q36628049-6A2EB442-392F-44B4-9FFE-E3A81834E191
wdt:P433
30
wdt:P478
24
p:P356
wds:Q36628049-3AEAE296-80FA-46ED-826B-061FEA1D1242
wdtn:P356
n10:JCO.2006.06.7595
wdt:P356
10.1200/JCO.2006.06.7595